ETR:SHL - Siemens Healthineers Stock Price, News, & Analysis Sign in or create an account to add this stock to your watchlist. Get Started €36.66 +0.24 (+0.66 %) (As of 05/21/2019 08:27 AM ET)Previous Close€36.42Today's Range€36.35 - €36.7752-Week Range€31.90 - €39.95Volume65,878 shsAverage VolumeN/AMarket Capitalization$36.64 billionP/E Ratio26.76Dividend Yield1.84%BetaN/A ProfileAnalyst RatingsChartHeadlines Share on FacebookShare on TwitterShare on LinkedInShare on RedditShare on StocktwitsPrint this articleShare by Email Siemens Healthineers AG develops, manufactures, and distributes imaging, advanced therapies, and diagnostic products and services to healthcare providers worldwide. It operates in three operating segments: Imaging, Advanced Therapies, and Diagnostics. The Imaging segment provides diagnostic imaging and ultrasound systems and solutions. The Advanced Therapies segment offers advanced therapy products, services, and solutions to the therapy departments of healthcare providers. The Diagnostics segment provides diagnostic products and services, including a range of testing applications, in the areas of laboratory, point of care, and molecular diagnostics. Siemens Healthineers AG is based in Erlangen, Germany. Siemens Healthineers AG operates as a subsidiary of Siemens Aktiengesellschaft. Receive SHL News and Ratings via Email Sign-up to receive the latest news and ratings for SHL and its competitors with MarketBeat's FREE daily newsletter. Industry, Sector and Symbol Stock Exchange ETR Industry Diagnostics & Research Sub-IndustryN/A SectorMedical Current SymbolETR:SHL Previous Symbol CUSIPN/A CIKN/A Webwww.healthcare.siemens.de Phone49 69 6682 6602Debt Debt-to-Equity Ratio51.25 Current Ratio1.31 Quick Ratio0.83Price-To-Earnings Trailing P/E Ratio26.76 Forward P/E Ratio19.71 P/E GrowthN/A Sales & Book Value Annual Sales$13.81 billion Price / Sales2.65 Cash Flow€0.85 per share Price / Cash Flow43.00 Book Value€8.75 per share Price / Book4.19Profitability EPS (Most Recent Fiscal Year)N/A Net IncomeN/A Net MarginsN/A Return on EquityN/A Return on AssetsN/AMiscellaneous Employees50,300 Outstanding Shares999,428,992Market Cap$36.64 billion Next Earnings DateN/A OptionableNot Optionable Siemens Healthineers (ETR:SHL) Frequently Asked Questions What is Siemens Healthineers' stock symbol? Siemens Healthineers trades on the ETR under the ticker symbol "SHL." What price target have analysts set for SHL? 18 equities research analysts have issued 1-year target prices for Siemens Healthineers' shares. Their forecasts range from €34.00 to €43.00. On average, they expect Siemens Healthineers' stock price to reach €38.15 in the next twelve months. This suggests a possible upside of 4.0% from the stock's current price. View Analyst Price Targets for Siemens Healthineers. What is the consensus analysts' recommendation for Siemens Healthineers? 18 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Siemens Healthineers in the last year. There are currently 13 hold ratings and 5 buy ratings for the stock, resulting in a consensus recommendation of "Hold." View Analyst Ratings for Siemens Healthineers. Has Siemens Healthineers been receiving favorable news coverage? Press coverage about SHL stock has been trending somewhat negative on Tuesday, InfoTrie reports. InfoTrie identifies negative and positive media coverage by analyzing more than six thousand news and blog sources in real-time. The firm ranks coverage of public companies on a scale of negative five to five, with scores nearest to five being the most favorable. Siemens Healthineers earned a news impact score of -1.1 on InfoTrie's scale. They also assigned media stories about the company a news buzz of 5.0 out of 10, indicating that recent media coverage is somewhat likely to have an impact on the company's share price in the near term. Who are some of Siemens Healthineers' key competitors? Some companies that are related to Siemens Healthineers include Sartorius (SRT), Carl Zeiss Meditec (AFX), NationalResearchCorp . (NRC), Integral Diagnostics (IDX), Senseonics (SENS), Senseonics (SENS), Akumin (AKU), Palatin Technologies (PTN), Renalytix Ai (RENX), Profound Medical (PRN), MaxCyte (MXCT), Yourgene Health (YGEN), Oncimmune (ONC), Lexagene (LXG) and Sernova (SVA). What other stocks do shareholders of Siemens Healthineers own? Based on aggregate information from My MarketBeat watchlists, some companies that other Siemens Healthineers investors own include Ladder Capital (LADR), MGM Resorts International (MGM), Realogy (RLGY), Southern (SO), Whirlpool (WHR), CarGurus (CARG), LSI Industries (LYTS), THL Credit (TCRD), Boeing (BA) and Cummins (CMI). Who are Siemens Healthineers' key executives? Siemens Healthineers' management team includes the folowing people: Dr. Jochen Schmitz, CFO & Member of Management Board (Age 53)Mr. Michael Reitermann, Chief Markets & Diagnostics Officer and Member of Management Board (Age 57)Mr. Florian Flossmann, Head of Investor Relations What is Siemens Healthineers' stock price today? One share of SHL stock can currently be purchased for approximately €36.67. How big of a company is Siemens Healthineers? Siemens Healthineers has a market capitalization of $36.65 billion and generates $13.81 billion in revenue each year. Siemens Healthineers employs 50,300 workers across the globe. What is Siemens Healthineers' official website? The official website for Siemens Healthineers is http://www.healthcare.siemens.de. How can I contact Siemens Healthineers? The company can be reached via phone at 49 69 6682 6602. MarketBeat Community Rating for Siemens Healthineers (ETR SHL)Community Ranking: 1.9 out of 5 ()Outperform Votes: 92 (Vote Outperform)Underperform Votes: 147 (Vote Underperform)Total Votes: 239MarketBeat's community ratings are surveys of what our community members think about Siemens Healthineers and other stocks. Vote "Outperform" if you believe SHL will outperform the S&P 500 over the long term. Vote "Underperform" if you believe SHL will underperform the S&P 500 over the long term. You may vote once every thirty days. This page was last updated on 5/21/2019 by MarketBeat.com StaffFeatured Article: Understanding Options Trading Receive Analysts' Upgrades and Downgrades Daily Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.